Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-29
1995-05-09
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514332, 514335, 546255, 546256, 546261, 546262, 546264, 546266, C07D40114, A61K 3144, A61K 3150, A61K 3153
Patent
active
054140030
ABSTRACT:
Pyridinylmethyl-substituted pyridines and pyridones are prepared by reacting pyridine- or pyridone-substituted halogenopyridines with tetrazolylphenylboronic acids. The substances according to the invention can be used as active compounds in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.
REFERENCES:
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5149699 (1992-09-01), Ellingboe et al.
patent: 5155117 (1992-10-01), Reitz
patent: 5196537 (1993-03-01), Reitz
E. L. Eliel, Stereochemistry of Carbon Compounds, McGraw Hill, 1962, 6 pgs.
The Journal of Cell Biology, vol. 5, 1971, pp. 172-186; "The Smooth Muscle Cell . . . ", R. Ross.
Beuck Martin
Bischoff Hilmar
Denzer Dirk
Dressel Jurgen
Fey Peter
Bayer Aktiengesellschaft
Davis Zinna N.
Ivy C. Warren
LandOfFree
Pyridinylmethyl-substituted pyridines and pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinylmethyl-substituted pyridines and pyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinylmethyl-substituted pyridines and pyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705516